Letter to Shareholders as per regulation 36(1)(b) of LODR
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Drugs Ltd has sent a letter to shareholders whose email addresses are not registered, informing them that the Annual Report for FY 2024-25 is available on the company's website. The company's 30th Annual General Meeting (AGM) is scheduled for Tuesday, 30th September 2025 at 09:30 AM IST, to be held via Video Conferencing (VC) or Other Audio Visual Means (OAVM). Shareholders are urged to update their email IDs with their Depository Participants to receive future communications electronically. The filing complies with Regulation 36(1)(b) of SEBI LODR Regulations, 2015. The letter is signed by Managing Director Nagi Reddy Seelam (DIN: 01764665).
This is a routine regulatory compliance filing with no material impact on the stock price. Shareholders who have not registered their email IDs should update them with their depository participants to receive the AGM notice and annual report electronically.